Anabiosis Medisciences Limited, a active public limited company, was established on 24 June 2004 in Ahmedabad, Gujarat, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24231GJ2004PLC044358. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹1.05 Cr and a paid-up capital of ₹1.05 Cr.
It upholds a compliant status. Employing 27 professional, Its leadership includes Jyoti Jaiswal (Director), Siddharth Rajkumar Jaiswal (Director), Raj Kumar Jaiswal (Managing Director). Past directors included Anil Kumar Singh, Jyoti Jaiswal, Siddharth Rajkumar Jaiswal. It holds ₹1.68 Cr open charges and no settled loans. Its latest AGM occurred on 11 November 2023, with the balance sheet filed on 31 March 2023. It is based at 69, Greenpark Bunglows, Opp : City Gold Cinema, Nr. Ambali Gam, Uma Partyplot, Bopal, Ahmedabad, Gujarat, 380058.
U24231GJ2004PLC044358
044358
24 June 2004
₹1.05 Cr
₹1.05 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Anabiosis Medisciences Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jyoti Jaiswal | Director | 18 Aug 2020 | Current |
| Siddharth Rajkumar Jaiswal | Director | 18 Aug 2020 | Current |
| Raj Kumar Jaiswal | Managing Director | 24 Jun 2004 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 24 Aug 2013 | Past |
| Pramod Abcsdd | Additional Director | 30 Dec 2020 | Past |
| Pramod Abcsdd | Additional Director | 30 Dec 2020 | Past |
| Pramod Abcsdd | Director | 27 Nov 2009 | Past |
| Pramod Abcsdd | Director | 18 Aug 2020 | Past |
| Pramod Abcsdd | Director | 18 Aug 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Anabiosis Medisciences Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 13.1% decrease. The company also saw a substantial fall in profitability, with a 596.81% decrease in profit. The company's net worth Soared by an impressive increase of 263.74%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Anabiosis Medisciences had a promoter holding of 93.10% and a public holding of 6.90%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹16,800,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 May 2008 | Canara Bank | ₹1.68 Cr | Open |
Explore comprehensive loan charge details -
Anabiosis Medisciences has a workforce of 27 employees as of Feb 17, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Anabiosis Medisciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anabiosis Medisciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Anabiosis Medisciences Limited last Annual general meeting of members was held on 11 Nov 2023 as per latest MCA records. was completed.
The activity A charge with Canara Bank of Rs. 1.68 Cr registered on 10 May 2008 with Charge ID 10145215 was modified on 01 May 2023. was completed.
The activity Anabiosis Medisciences Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Ahmedabad. was completed.
The activity Jyoti Jaiswal was appointed as a Director was appointed as a Director on 18 Aug 2020 & has been associated with this company since 5 years 3 months . was completed.
Progress on Siddharth Rajkumar Jaiswal was appointed as a Director was appointed as a Director on 18 Aug 2020 & has been associated with this company since 5 years 3 months . was documented.
The activity A charge with Canara Bank amounted to Rs. 1.68 Cr with Charge ID 10145215 was registered on 10 May 2008. was completed.
The CIN of Anabiosis Medisciences Limited is U24231GJ2004PLC044358.
Anabiosis Medisciences Limited is headquartered at 69, Greenpark Bunglows, Opp : City Gold Cinema, Nr. Ambali Gam, Uma Partyplot, Bopal, Ahmedabad, Gujarat, 380058.
Anabiosis Medisciences Limited was incorporated on 24 June 2004.
The current directors of Anabiosis Medisciences Limited are
The primary industry of Anabiosis Medisciences Limited is Trade.
Anabiosis Medisciences Limited is unlisted.
The authorized capital of Anabiosis Medisciences Limited is ₹1.05 Cr, and the paid-up capital is ₹1.05 Cr.
The compliance status of Anabiosis Medisciences Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX